Pat PurcellMeeting Engagement
Matthew DurhamOmnidynamic Marketing
Liz KaneImpactful Strategy
Stacey GandlerBrand Nourishment
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Paul TheisenPatient Acquisition
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
Suma Ramadas, PhDMedical Affairs
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
The first stage of the Phase IIa study with YELIVA® for advanced cholangiocarcinoma (bile ...
Significant reduction of proteinuria compared to irbesartan Statistically significant difference in modified partial remission; ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email
